Vicki (Mughmaw) Keedy MD MSCI

Oncology•Nashville, TN

Sarcoma

Associate Professor, Medicine, Vanderbilt University School of Medicine

Join to View Full Profile

3601 21st Ave SNashville, TN 37232
Phone+1 615-936-2000
Fax+1 615-936-0605

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Vanderbilt University Medical CenterResidency, Internal Medicine, 2002 - 2005
University of Cincinnati College of MedicineClass of 2002

Certifications & Licensure

TN State Medical License 2008 - 2026
AL State Medical License 2020 - 2020
American Board of Internal Medicine Medical Oncology

Clinical Trials

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer Start of enrollment: 2000 Dec 01
Completed
Not Applicable
Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer Start of enrollment: 2009 May 01
Terminated
Phase 1
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
Completed
Phase 2
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma Start of enrollment: 2013 Mar 01
Terminated
Not Applicable
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
Completed
Phase 2
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
Completed
Phase 3
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
COMPLETED
PHASE3
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
Completed
Phase 1, Phase 2
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) Start of enrollment: 2017 Aug 15
Active, not recruiting
Phase 3
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2019 Aug 13
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

2 citations
Diagnosis and management of dedifferentiated liposarcoma: A multidisciplinary position statement.
Candace L Haddox, Jason L Hornick, Christina L Roland, Elizabeth H Baldini, Vicki L Keedy
Cancer Treatment Reviews. 2024-12-01
Brain Metastases in Sarcomas: A Multicenter Retrospective Cohort Study.
Ellen Zhang, Sheima Farag, Hilary Dietz, Daniel Wang, Angela Hirbe
Cancers. 2024-11-07
42 citations
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia
Lancet. 2024-04-13

Press Mentions

$Study Finds High-Dose Ifosfamide Superior to Other Standard-of-Care Treatments in Recurrent and Primary Refractory Ewing Sarcomas$
Study Finds High-Dose Ifosfamide Superior to Other Standard-of-Care Treatments in Recurrent and Primary Refractory Ewing SarcomasJune 5th, 2022
An 'Intriguing Failure' in Advanced, Pre-Treated GISTJanuary 26th, 2022
Berlin Assumes New VICC Leadership PostMay 29th, 2018
Join now to see all

Vicki (Mughmaw) Keedy MD MSCI

Dr. Keedy is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.